Quon CY[au] - Search Results

Year	Number of Results
1985	1
1986	2
1988	3
1989	1
1990	1
1992	1
1993	3
1994	9
1995	3
1996	1
1997	1
2002	1
2003	1
2022	0

1

Pharmacology and pharmacokinetics of esmolol.

Reynolds RD, Gorczynski RJ, Quon CY. Reynolds RD, et al. Among authors: quon cy. J Clin Pharmacol. 1986 Mar;26(S1):A3-A14. doi: 10.1002/j.1552-4604.1986.tb02985.x. J Clin Pharmacol. 1986. PMID: 2870084

2

Biochemical properties of blood esmolol esterase.

Quon CY, Stampfli HF. Quon CY, et al. Drug Metab Dispos. 1985 Jul-Aug;13(4):420-4. Drug Metab Dispos. 1985. PMID: 2863104

3

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. Molinoff PB, et al. Among authors: quon cy. Ann N Y Acad Sci. 2003 Jun;994:96-102. doi: 10.1111/j.1749-6632.2003.tb03167.x. Ann N Y Acad Sci. 2003. PMID: 12851303 Clinical Trial.

4

Species differences in the stereoselective hydrolysis of esmolol by blood esterases.

Quon CY, Mai K, Patil G, Stampfli HF. Quon CY, et al. Drug Metab Dispos. 1988 May-Jun;16(3):425-8. Drug Metab Dispos. 1988. PMID: 2900735

5

The effect of hepatic disease on the disposition of moricizine in humans.

Pieniaszek HJ Jr, Davidson AF, McEntegart CM, Quon CY, Sampliner RE, Mayersohn M. Pieniaszek HJ Jr, et al. Among authors: quon cy. Biopharm Drug Dispos. 1994 Apr;15(3):243-52. doi: 10.1002/bdd.2510150306. Biopharm Drug Dispos. 1994. PMID: 7880984

6

Pharmacodynamics and onset of action of esmolol in anesthetized dogs.

Quon CY, Gorczynski RJ. Quon CY, et al. J Pharmacol Exp Ther. 1986 Jun;237(3):912-8. J Pharmacol Exp Ther. 1986. PMID: 2872328

7

Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.

Grubb MF, Wong YN, Burcham DL, Saxton PL, Quon CY, Huang SM. Grubb MF, et al. Among authors: quon cy. Drug Metab Dispos. 1994 Sep-Oct;22(5):709-12. Drug Metab Dispos. 1994. PMID: 7835221

8

The effect of absorption enhancers on the oral absorption of the GP IIB/IIIA receptor antagonist, DMP 728, in rats and dogs.

Burcham DL, Aungst BA, Hussain M, Gorko MA, Quon CY, Huang SM. Burcham DL, et al. Among authors: quon cy. Pharm Res. 1995 Dec;12(12):2065-70. doi: 10.1023/a:1016289200422. Pharm Res. 1995. PMID: 8786991 No abstract available.

9

Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoin.

Gerber N, Mays DC, Donn KH, Laddu A, Guthrie RM, Turlapaty P, Quon CY, Rivenburg WK. Gerber N, et al. Among authors: quon cy. J Clin Pharmacol. 1988 Nov;28(11):1023-32. doi: 10.1002/j.1552-4604.1988.tb03124.x. J Clin Pharmacol. 1988. PMID: 3243914

10

The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.

Christ DD, Wong PC, Wong YN, Hart SD, Quon CY, Lam GN. Christ DD, et al. Among authors: quon cy. J Pharmacol Exp Ther. 1994 Mar;268(3):1199-205. J Pharmacol Exp Ther. 1994. PMID: 8138932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results